JPRN-UMIN000010445已完成未知
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type2 diabetes - Comparison of DPP-4 inhibitors, vildagliptin and linagliptin
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)severe ketosis, diabetic coma within 6 months 2)severe infection, before operation, severe trauma 3)severe hepatic dysfunction 4)or severe renal dysfunction (SCr:more than 2.0mg/dl or eGFR less than 30) 5)pregnacy 6)Allergy for vildagliptin, linagliptin, repaglinide and glimepiride 7)Patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
已完成
不适用
Comparison of DPP-4 inhibitor, sitagliptin and nateglinide, and liraglutide and exenatide in type 2 diabetes: a CGM based-studyType 2 diabetes mellitusJPRN-UMIN000006799Yokohama City University Medical Center80
进行中（未招募）
1 期
correlation between gastric motility and appetitehealthy volunteersno medical condition, drug will be studied because they are known to influence gastric motilityEUCTR2013-004978-95-BEKULeuven14
已完成
4 期
Comparison of DPP-4 Inhibitors versus Dapagliflozin in combination with insulin using continuous glucose monitoring in patients with type 2 diabetes mellitus -prospective randomized controlled trialtype 2 diabetes mellitusJPRN-UMIN000015033Hokkaido University Hospital36
已完成
不适用
Comparison of DPP4 inhibitors versus luseogliflozin, a SGLT2 inhibitor using cotinuous glucose monitoring (CGM)type 2 diabetesJPRN-UMIN000014333Ichinomiyanishi hospital20
已完成
不适用
Effects of DPP4 inhibitor, sitagliptin or Sulfonylurea on intrahepatic adipose mass and lipid metabolism in patients with type 2 diabetes accompanied by fatty liver : a prospective randomized, open-label trialType 2 diabetesJPRN-UMIN000013356St.Marianna University School of Medicine60